BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27313063)

  • 1. Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials.
    Peter B; Bosze S; Horvath R
    Eur Biophys J; 2017 Jan; 46(1):1-24. PubMed ID: 27313063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
    Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
    J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea polyphenol epigallocatechin-3-gallate attenuates TNF-α-induced intercellular adhesion molecule-1 expression and monocyte adhesion to retinal pigment epithelial cells.
    Thichanpiang P; Wongprasert K
    Am J Chin Med; 2015; 43(1):103-19. PubMed ID: 25644976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
    Ahmad N; Gupta S; Mukhtar H
    Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria.
    Weng Z; Zhou P; Salminen WF; Yang X; Harrill AH; Cao Z; Mattes WB; Mendrick DL; Shi Q
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1097-104. PubMed ID: 24384371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-
    Saeki K; Hayakawa S; Nakano S; Ito S; Oishi Y; Suzuki Y; Isemura M
    Molecules; 2018 May; 23(6):. PubMed ID: 29843451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.
    Benelli R; Venè R; Bisacchi D; Garbisa S; Albini A
    Biol Chem; 2002 Jan; 383(1):101-5. PubMed ID: 11928805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N; Cheng P; Mukhtar H
    Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
    Yang C; Du W; Yang D
    Int J Food Sci Nutr; 2016 Nov; 67(7):818-27. PubMed ID: 27338284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.
    Park JW; Hong JS; Lee KS; Kim HY; Lee JJ; Lee SR
    J Nutr Biochem; 2010 Nov; 21(11):1038-44. PubMed ID: 19962294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
    Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
    James KD; Forester SC; Lambert JD
    Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties.
    Azam S; Hadi N; Khan NU; Hadi SM
    Toxicol In Vitro; 2004 Oct; 18(5):555-61. PubMed ID: 15251172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
    Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
    Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Great green tea ingredient? A narrative literature review on epigallocatechin gallate and its biophysical properties for topical use in dermatology.
    Frasheri L; Schielein MC; Tizek L; Mikschl P; Biedermann T; Zink A
    Phytother Res; 2020 Sep; 34(9):2170-2179. PubMed ID: 32189392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53.
    Hofmann CS; Sonenshein GE
    FASEB J; 2003 Apr; 17(6):702-4. PubMed ID: 12586742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.